| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.97B | 35.29B | 32.58B | 31.65B | 30.59B | 29.38B |
| Gross Profit | 13.41B | 13.50B | 13.16B | 12.86B | 12.52B | 11.93B |
| EBITDA | 8.20B | 8.46B | 7.93B | 7.57B | 7.50B | 7.34B |
| Net Income | 3.23B | 4.21B | 3.12B | 3.13B | 3.02B | 3.04B |
Balance Sheet | ||||||
| Total Assets | 67.33B | 69.76B | 66.88B | 58.81B | 55.90B | 53.41B |
| Cash, Cash Equivalents and Short-Term Investments | 8.19B | 11.43B | 7.17B | 10.87B | 12.80B | 14.22B |
| Total Debt | 0.00 | 0.00 | 0.00 | 1.30B | 1.10B | 587.00M |
| Total Liabilities | 7.12B | 8.08B | 7.15B | 5.33B | 4.89B | 5.34B |
| Stockholders Equity | 60.20B | 61.67B | 59.73B | 53.48B | 51.01B | 48.07B |
Cash Flow | ||||||
| Free Cash Flow | 1.92B | 2.48B | -765.00M | -961.00M | 1.06B | 2.72B |
| Operating Cash Flow | 1.92B | 4.39B | 1.14B | 524.00M | 2.20B | 3.15B |
| Investing Cash Flow | 0.00 | 1.41B | -3.81B | -1.43B | -3.25B | -3.15B |
| Financing Cash Flow | 0.00 | -1.53B | -1.03B | -1.02B | -377.00M | -351.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥97.23B | 15.89 | ― | 3.63% | 35.73% | 62.37% | |
73 Outperform | ¥95.40B | 24.41 | ― | 0.96% | 4.12% | 23.44% | |
68 Neutral | ¥173.05B | 9.00 | ― | 2.89% | 20.38% | 128.85% | |
64 Neutral | ¥121.03B | 13.33 | ― | 2.13% | 7.22% | 21.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |